Post Marketing Surveillance

Post-marketing surveillance (PMS) is a critical phase of pharmaceutical regulatory science, focusing on monitoring the safety of medications after they are released on the market. It helps in identifying and evaluating previously unreported adverse effects and interactions, ensuring the ongoing assessment of the risk-benefit balance of drugs. PMS data contribute to updating drug labels, informing healthcare professionals and the public, and may lead to regulatory actions such as modifying dosage recommendations or withdrawing drugs if necessary.

Post-marketing surveillance (PMS) is a vital phase in the lifecycle of pharmaceutical products, aimed at ensuring their ongoing safety once they have entered the market. Through PMS, regulatory authorities and drug manufacturers collect and analyze real-world data on adverse drug reactions, thereby gaining insights into the drug's performance in a broader patient population. This continuous monitoring helps in identifying rare or long-term side effects not detected during the initial clinical trials, ensuring that healthcare professionals and patients are informed about the benefits and risks of medications, leading to safer use of drugs.

    Related Conference of Post Marketing Surveillance

    June 23-24, 2025

    38th World Congress on Pharmacology

    Paris, France
    August 18-19, 2025

    40th World Congress on Pharmacology and Therapeutics

    Valencia, Spain
    September 19-20, 2025

    18th World Drug Delivery Summit

    Paris, France
    September 22-23, 2025

    Pharma Biotech Expo

    Toronto, Canada
    September 23-24, 2025

    10th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    November 13-14, 2025

    21st International Conference on Pharmaceutical Chemistry

    Aix-en-Provence, France
    November 20-21, 2025

    21st Annual Congress on Pharmacology and Toxicology

    Paris, France
    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 27-28, 2025

    13th International Conference on Clinical Trials

    Amsterdam, Netherlands
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, Aland Islands
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands

    Post Marketing Surveillance Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in